As such, tumor‐specific CD8+ T‐cell responses may exhibit unique patterns of functional competence and at a practical level this indicates that the choice of IFN‐γ ELIPSOT as a functional test is likely to have underestimated the true frequency of CTAg‐specific T cells. The gene discussed is CD8A; the disease is neoplasm.